OIL

5.71%

16.5¢ optiscan imaging limited

"The fact that OIL has only five quarters of funding remaining...

First 5 Last

Share
Profile

Follow
BuffettWarren

1,727 Posts.

201

30/04/24

16:45

Post #: 73589160
Share

Originally posted by grussellt: ↑

The share price movement today seems to suggest a bullish tone in the quarterly report..

However I have some reservation regarding the following quotes:
"Due to the complexity of the FDA regulatory pathway required for the Company’s combination (device/drug) suite of products including its future software as a medical device (SaMD)..................
The Company continues to work with the FDA on the suitability of its topical fluorescein approach for oral tissue imaging following feedback received from the Agency late in 2023. Given the requirement for a contrast agent for successful deployment of the Optiscan devices, coupled with the new regulatorychanges around contrast agents being classified as drugs, and the feedback and advice received from the FDA, the Company has commenceddiscussions with drug manufacturers to find appropriate alternate pathways to resolve the issues raised by the Agency in relation to the novel topical use of fluorescein.
The Company is also concurrently exploring alternative approaches for non-topical fluorescein use, which may facilitate the progress of the InVivage® submission through alternative means, and simultaneously streamline discussions around the Company’s other devices with the Agency. The FDA have granted the Company additional time to explore these alternatives before finalising its latest Q-submission guidance. It is anticipated that these dealings will take place by end of Q4FY24, after which a decision will be made on the most appropriate path forward and the relevant clinical studies required to demonstrate utility and efficacy for oral imaging."

This is a quarterly that needs careful reading and interpretation, but we don't have the facts to try and estimate the time required for FDA appproval.
The fact that OIL has only five quarters of funding remaining (on a farly simplistic method for budgeting) suggests another fund raising will be necessary for product launch(es).

Expand

"The fact that OIL has only five quarters of funding remaining (on a farly simplistic method for budgeting) suggests another fund raising will be necessary for product launch(es)."

I'd suggest that's a given. The unknown is at what price will it be able to be done at?

OIL Price at posting: 8.9¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

There are more pages in this discussion • 19 more messages in this thread...

First 5 Last

Add OIL (ASX) to my watchlist

(20min delay)
Last 16.5¢		Change -0.010(5.71%)		Mkt cap ! $137.8M

Open	High	Low	Value	Volume
17.5¢	17.5¢	16.5¢	$16.50K	97.44K

Buyers (Bids)

No.	Vol.	Price($)
5	168328	16.5¢

Sellers (Offers)

Price($)	Vol.	No.
17.0¢	25000	1

View Market Depth

No.	Vol.	Price($)
3	150000	0.165
5	266250	0.160
2	450000	0.155
4	54268	0.150
1	30070	0.145

Price($)	Vol.	No.
0.190	39837	3
0.195	121821	2
0.200	542000	3
0.205	161553	3
0.210	9440	2

Last trade - 11.27am 04/10/2024 (20 minute delay)

OIL (ASX) Chart

"The fact that OIL has only five quarters of funding remaining...

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

"The fact that OIL has only five quarters of funding remaining...

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News